FDA Clarifies Labeling Expectations for Prescription Drug Use-Related Software | Sheppard Mullin Richter & Hampton LLP
On September 19, 2023, the U.S. Food and Drug Administration (“FDA” or “the Agency”) published a draft guidance, Regulatory Considerations for Prescription Drug Use-Related Software...
Source: jdsupra.com